Apotex Faces Uncertainty After Founder's Mysterious Death

The path forward for Apotex is uncertain following the sudden death of founder and chairman Barry Sherman, who was the architect of the generic drugmaker’s litigation-heavy strategy.

from WSJ.com: US Business http://ift.tt/2Cii8xT
via IFTTT